ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS : vimarsan

DUBLIN, May 8, 2023 /PRNewswire/ -- Endo International plc today reported financial results for the first-quarter ended March 31, 2023.




... | May 8, 2023

Related Keywords

Dublin , Ireland , Canada , Canadian , , Prnewswire Endo International , Company Loss , International Pharmaceuticals , Takeda Pharmaceutical United Statesa Inc , Pfizer Inc , Branded Pharmaceuticals , Company Chapter , Paladin Labs Inc , Linkedin , Endo International , Exchange Commission , Endo Investor Relations Department , Generic Pharmaceuticals , Takeda Pharmaceuticals United States Inc , Months Ended March , Diluted Net Loss , Continuing Operations , Diluted Weighted Average Shares , Diluted Net Income , Adjusted Diluted Weighted Average Shares , Adjusted Income , Adjusted Diluted Net Income , Sterile Injectables , Note Regarding Forward Looking Statements , Gross Margin , Total Revenues , Takeda Pharmaceutical United Statesa , Nasal Spray , Takeda Pharmaceuticals United States , Paladin Labs , Condensed Consolidated Statement , Condensed Consolidated Balance Sheet , Cash Flow , Qualified Settlement , Current Report , Supplemental Financial Information , Condensed Consolidated Statements , Accounting Standards Codification Topic , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports , Endo International Plc Stock Exchange , News , Information , Press Release , Bay , 023 , Undo , Nternational , Lc , Oday , Eported , Financial , Results , Or , The , Nded Endpq Ie00bj3v9050 ,